Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,967
Total Claims
$1.7M
Drug Cost
871
Beneficiaries
$1,930
Cost/Patient
Risk Score Breakdown 20/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-30%
Opioid rate vs peers
1.6% vs 2.2% avg
+37%
Cost per patient vs peers
$1,930 vs $1,411 avg
+54%
Brand preference vs peers
16.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.6%
Opioid Rate
157
Opioid Claims
$6,325
Opioid Cost
18.5%
Long-Acting Rate
Brand vs Generic
Brand: 1,605 claims · $1.4M
Generic: 8,211 claims · $256K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 172 | $303K |
| Dulaglutide | 80 | $98K |
| Empagliflozin | 66 | $84K |
| Tirzepatide | 62 | $76K |
| Fluticasone/Umeclidin/Vilanter | 98 | $68K |
| Apixaban | 73 | $62K |
| Sitagliptin Phosphate | 54 | $57K |
| Bictegrav/Emtricit/Tenofov Ala | 13 | $55K |
| Rivaroxaban | 31 | $52K |
| Sitagliptin Phos/Metformin Hcl | 44 | $52K |
| Dapagliflozin Propanediol | 35 | $51K |
| Insulin Degludec | 42 | $46K |
| Sitagliptin Phos/Metformin Hcl | 27 | $38K |
| Linaclotide | 33 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 43 | $34K |
Prescribing Profile
Patient Profile
73
Avg Age
51%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About